Published 2026-04-10 • Price-Quotes Research Lab Analysis

Penn Medicine researchers analyzed billing data across their health system and found that telemedicine visits were billed $400 less on average than in-person appointments for conditions treatable by both modalities. That is not a rounding error. That is a structural cost advantage that reshapes how Americans should think about primary care spending in 2026. Price-Quotes Research Lab dug into the numbers across five major metros—New York City, Los Angeles, Chicago, Houston, and Phoenix—to map exactly where that money goes and who benefits.
The telehealth infrastructure that exploded during COVID-19 has matured into a permanent tier of the healthcare system. Medicare's pandemic-era telehealth expansions were extended through federal policy action, keeping virtual care coverage intact for seniors. Private insurers have largely maintained expanded telehealth benefits, and employer-sponsored plans increasingly bundle virtual primary care into wellness packages. Yet the pricing architecture remains opaque. Most patients do not know what a telehealth visit actually costs until they receive a bill—because the numbers vary wildly by platform, by city, by insurance status, and by whether they are a new or returning patient.
This analysis cuts through that noise. We focus specifically on a new-patient, 15-minute primary care visit—the most common virtual care encounter—comparing telehealth platforms against traditional in-office primary care across all five cities. We present cash prices, typical insurance allowed amounts, and subscription fee structures so readers can calculate their actual exposure before they book an appointment.
Understanding telehealth costs requires separating the components that make up a single visit. According to Cost Digest's 2026 telemedicine price guide, a telemedicine encounter consists of three layers: the clinician fee, the platform or facility charge, and any add-on costs for prescriptions, lab orders, or follow-up communications. When you book a $60 telehealth visit, you are often paying $45 to the clinician and $15 to the platform as an access fee. Membership models collapse the platform fee into a monthly subscription, creating a different cost curve for frequent users.
The Virtual Visit Pricing Guide segments telehealth into three tiers for 2026. Tier 1 covers urgent care and on-demand single-issue visits at $40–$75 per encounter. Tier 2 encompasses primary care membership models at $15–$50 per month, typically offering unlimited or heavily discounted follow-up virtual visits. Tier 3 involves specialist consultations ranging from $75–$200 depending on the specialty and platform. For this analysis, we focus on Tier 2 primary care virtual visits—the direct telehealth equivalent of a traditional new-patient office consultation.
Before we go city by city, the national baseline matters. LatestCost's 2026 PCP pricing data establishes the following out-of-pocket ranges for a new-patient primary care visit. Cash payment (no insurance) for a standard new-patient visit runs $100–$250 depending on region and provider. With insurance using a copay, costs land between $10–$50 depending on plan design. If the patient has not yet met their deductible, they pay the full negotiated rate, which typically ranges from $100–$200 or more depending on the insurance allowed amount. Telehealth PCP visits without insurance fall between $40–$100 per encounter. The gap between telehealth and in-person is stark at every insurance tier.
Doseway's complete pricing breakdown confirms these ranges and adds important nuance: prescription support runs $0–$40 per prescription, lab orders add $0–$100, and delivery or communication fees for follow-up messaging can run $0–$25 per contact. None of these appear in the headline visit price, which is why patients frequently receive surprise bills after what they thought was a $50 telehealth visit.
New York City occupies the top of every healthcare cost ranking in the country, and the telehealth versus in-person comparison is no exception. For a new-patient 15-minute telehealth visit in NYC, cash prices range from $70–$110 without insurance. The higher end reflects Manhattan-based platforms with board-certified internists and concierge-style interfaces. Insurance allowed amounts—the figure that determines what a commercially insured patient actually pays after coinsurance—typically range from $55–$85 for telehealth in NYC, compared to $130–$180 for a traditional office visit in the same market.
In-person new-patient PCP visits in New York City run $175–$350 cash for a 15-minute encounter, with MDsave pricing data confirming that new-patient office visits in NYC frequently exceed $250 when billed as self-pay at independent practices. Specialist referral pathways from a PCP visit can add $50–$150 in additional coinsurance obligations that do not apply when a telehealth platform handles the initial consultation directly.
The hidden cost differential in NYC goes beyond the visit itself. Parking in Manhattan averages $25–$45 for a medical appointment. Transit time from outer boroughs can consume 60–90 minutes each direction. Childcare arrangements for parents attending appointments add $20–$60 in direct costs. Telehealth eliminates all of these friction costs, and Price-Quotes Research Lab estimates that when indirect expenses are factored in, the true cost advantage of telehealth for NYC residents averages $120–$180 per visit compared to in-office care.
Los Angeles presents the widest dispersion of any city in our analysis. Telehealth cash prices range from $65–$95 for a new-patient 15-minute virtual visit, with platform fees accounting for $15–$30 of that figure at non-membership operators. GoodRx's telehealth cost analysis notes that LA's competitive telehealth market has compressed prices at the lower end, with CVS Health and Amazon Clinic offering $40–$55 cash visits for common primary care complaints.
In-person new-patient PCP costs in Los Angeles run $160–$320 cash, with significant variation by neighborhood. Beverly Hills and Westside practices regularly charge $275–$350 for a new-patient visit, while community health centers and chain retail clinics in South LA and the San Fernando Valley offer rates closer to $110–$160. Insurance allowed amounts for in-person visits in LA range from $120–$260 depending on the practice's contracted rate with commercial payers.
LA's specific telehealth dynamics include strong penetration of employer-sponsored virtual care programs. Major entertainment industry unions and tech employers have negotiated $0 copay telehealth benefits that bring virtual care costs to effectively nothing for employees. However, FairVisitHealth's 2026 primary care pricing data warns that these employer-negotiated rates do not transfer to uninsured patients or those covered by Medicaid managed care plans, who face the full cash prices listed above.
Chicago benefits from a healthcare market that remains more consolidated than coastal metros, which paradoxically creates more predictable pricing. Telehealth cash prices for new-patient visits range from $50–$80, with Northwestern Medicine's digital health platform and AMITA Health's virtual care offerings anchoring the upper end, while Chicago-based startup platforms like DocPanel and Zulia offer $45–$65 cash rates to compete on price.
In-person new-patient PCP visits in Chicago cost $130–$275 cash. Mira's 2026 primary care pricing data confirms that Chicago's large network of academic medical centers (University of Chicago Medicine, Northwestern, Rush) creates a tiered pricing structure where attending-physician visits command $200–$275 while resident-staffed clinics offer $95–$130 for the same visit type. This academic discount is not available via telehealth platforms, which do not distinguish between clinician training levels in their pricing.
The insurance in Chicago favors telehealth more than any other city in our analysis. Blue Cross Blue Shield of Illinois maintains telehealth-first primary care contracts with several regional insurers that reimburse virtual visits at $35–$50 versus $65–$85 for in-person, creating a copay differential that directly incentivizes patients to choose virtual care. Patients with high-deductible health plans who have not yet met their deductible face $80–$160 for in-person visits against $45–$75 for telehealth—a difference that compounds over multiple annual visits.
Houston's healthcare market reflects its oil industry roots: vast wealth concentrated in specific corridors, with significant affordability challenges in underserved neighborhoods. Telehealth cash prices range from $45–$75 for a new-patient virtual visit, placing Houston below LA and NYC but above Phoenix on the cost curve. The Texas Medical Center—the world's largest medical complex—hosts several telehealth platforms that price at the higher end, while independent Texas-based telehealth providers like Community Health Choice Virtual Care offer $40–$55 cash visits.
In-person new-patient PCP costs in Houston run $120–$260 cash. Galileo's 2026 pricing guide for doctor visits without insurance places Houston at the lower end of major metropolitan averages, reflecting Texas's generally lower healthcare regulatory burden and competitive market for primary care physicians. However, the Texas prohibition on midlevel practitioner independent practice means that nurse practitioner and physician assistant visits—which are cheaper in most states—require physician supervision overhead that gets built into visit pricing.
Houston's Medicaid managed care creates an interesting telehealth dynamic. Texas Medicaid covers telehealth in all 50 states under federal requirements, but Texas's relatively restrictive scope of telehealth coverage compared to other expansion states means that some platform features (store-and-forward imaging, remote patient monitoring) may not qualify for reimbursement. Patients relying on Medicaid managed care should verify their plan's specific telehealth coverage before booking virtual appointments to avoid balance billing.
Phoenix offers the most affordable healthcare of any major metro in our analysis, and the telehealth comparison reflects this. Cash prices for a new-patient telehealth visit range from $40–$70, with Banner Health's virtual care platform and CVS Health MinuteClinic Virtual Care competing aggressively at the $35–$55 end of the range. Zocdoc's uninsured primary care pricing data confirms that Phoenix's rapid population growth has attracted heavy competition among telehealth providers, which has driven prices down faster than any other city in our analysis.
In-person new-patient PCP visits in Phoenix cost $110–$230 cash. The lower end reflects Value-based care organizations like ChenMed and Oak Street Health that serve Medicare Advantage populations with $0 copay visits as part of their model. Commercial practices in Scottsdale and Paradise Valley charge $175–$230 for new-patient visits, while community health centers and FQHC sites offer sliding-scale pricing that can drop costs to $60–$90 for qualifying patients. Critically, Phoenix's network of retail health clinics inside Walgreens, CVS, and Walmart offer in-person new-patient visits for $75–$110, which narrows—but does not eliminate—the telehealth price advantage.
The per-visit comparison tells only part of the story. For patients who anticipate needing multiple primary care interactions annually, subscription membership models can reduce effective per-visit costs dramatically. Teladoc Health charges approximately $15–$22 per month for individual membership plans that include unlimited primary care virtual visits, mental health consultations, and dermatology access. At two visits per year, this yields an effective cost of $90–$132 annually—below the typical telehealth per-visit cash price in every city we analyzed.
Amwell's subscription model operates differently, charging $69–$89 per visit without insurance membership. However, Amwell is frequently included as a $0 copay benefit through employer-sponsored plans, which effectively eliminates the cost barrier entirely for employees of large companies. CVS Health's subscription program bundles telehealth access with prescription savings and lab testing discounts, creating a $20–$35 per month value proposition for patients with chronic condition management needs. One Medical's annual membership runs approximately $144–$199 per year for unlimited virtual visits with its network of primary care physicians—physician-attributed care that differs from pure telehealth platforms by offering continuity of relationship.
The most significant cost driver for insured patients is the copay structure. Commercial insurance plans in 2026 maintain a consistent pattern: telehealth copays range from $10–$30 while in-person primary care copays land between $25–$75 depending on plan metal tier. A patient on a Gold-tier HMO plan in Chicago pays $25 for a telehealth visit against $50 for an in-person visit. That $25 difference multiplied across four annual primary care visits yields $100 in annual savings—without factoring in indirect costs.
The deductible scenario creates even more dramatic swings. When patients have not yet met their annual deductible, they pay the insurance plan's allowed amount rather than a fixed copay. For telehealth, insurance allowed amounts typically range from $40–$80 per visit. For in-person PCP visits, allowed amounts run $100–$200 or more depending on the practice's contracted rate. A patient in NYC with a $1,500 deductible who has not yet satisfied it faces $130–$180 out-of-pocket for an in-person new-patient visit versus $55–$85 for telehealth. That patient saves $75–$95 per visit by choosing virtual care until they reach their deductible threshold.
Medicare's telehealth coverage was fundamentally restructured by the COVID-era expansions that have since been extended through federal policy action. Telehealth.org's analysis of 2026 Medicare telehealth policy confirms that Medicare now covers most telehealth services at the same rate as equivalent in-person visits. This parity mandate eliminates the cost advantage that telehealth previously held for Medicare beneficiaries, equalizing the $10–$40 copay for both modalities.
However, Medicare Advantage plans have introduced differentiated telehealth benefits that go beyond traditional Medicare. Medicare Advantage telehealth coverage data for 2026 shows that many MA plans offer $0 copay telehealth benefits for primary care, behavioral health, and urgent care visits—benefits not available for equivalent in-person services. Seniors enrolled in MA plans should verify their specific telehealth benefit structure before assuming costs are equivalent to in-person care.
Medicaid coverage varies by state, with Texas (Houston) maintaining more restrictive telehealth scope than Illinois or New York. CMS telehealth billing guidelines for 2026 establish baseline coverage, but states retain discretion over specific platforms, service types, and reimbursement rates within their Medicaid managed care contracts.
The $400 average billing savings documented by Penn Medicine's JAMA Network Open study is not just about the index visit. Researchers found that telemedicine visits resulted in fewer follow-up appointments than equivalent in-person encounters. Patients who received virtual care did not return for additional visits at the same rate as those who started with in-person consultations. This follow-up compression compounds the per-visit savings into total episode savings that are substantially larger than the headline figures suggest.
Co-senior author David Asch, MD, MBA, summarized the finding: telemedicine is a complete solution for many patients rather than merely a temporary band-aid that delays in-person care. The fear that virtual visits would create a revolving door of ineffective treatment was not borne out in the data. For conditions including respiratory infections, skin conditions, medication refills, and routine chronic disease management, telehealth produced equivalent or superior clinical outcomes at dramatically lower total cost.
ReJoy Health's analysis of the same study notes that mental and behavioral health treatment showed more variable cost results, with some platforms generating higher follow-up utilization for teletherapy. However, even in behavioral health, the per-session cost advantage of telehealth versus in-office therapy ($80–$120 telehealth versus $150–$250 in-person) creates significant cumulative savings for patients in ongoing treatment.
Telehealth cannot replace the physical examination, and that limitation creates a natural boundary on virtual care's cost-saving potential. A new-patient visit for abdominal pain, joint swelling, or ear concerns will frequently require an in-person follow-up that telehealth itself cannot provide. When that downstream visit is included, the total cost picture changes. A $75 telehealth visit that generates a $180 in-person follow-up totals $255—more expensive than a single $200 in-person PCP visit that addresses the problem comprehensively from the start.
The clinical algorithm matters more than the modality choice. Patients and their care coordinators should evaluate whether the presenting complaint is amenable to virtual resolution before defaulting to telehealth. Platforms including Teladoc and Amwell have begun offering algorithmic triage at booking that routes patients toward the appropriate modality based on chief complaint. Using these triage tools can prevent the scenario where a low-cost telehealth visit generates a high-cost in-person follow-up, converting a cost advantage into a cost liability.
Healthcare economists estimate that 30–40% of total care costs are indirect: transportation, lost wages, childcare, facility parking, and time away from work. These costs do not appear on any medical bill, but they structure every care-seeking decision. HCCI's HealthPrices.org price transparency data provides tools for consumers to access actual negotiated rates, but indirect costs remain outside the scope of pricing transparency regulations.
The indirect cost advantage of telehealth is most pronounced in the most expensive cities. A NYC patient spending $45 in transit costs plus 90 minutes of travel time (valued at $35–$45 in forgone wages) adds $80–$90 to an in-person visit that does not appear on the medical bill. A Phoenix patient paying $8 for parking and 20 minutes of transit adds $15–$20. The indirect cost premium for in-person care scales with urban density and income levels—exactly the markets where telehealth adoption is highest.
The Sage Transparency 2.0 dashboard and Trilliant Health's price transparency analytics provide machine-readable pricing files that allow consumers to look up actual contracted rates by CPT code, geography, and insurance plan. These tools are imperfect—data quality varies by hospital system, and consumer-facing interfaces remain clunky—but they represent the most accurate way to estimate true out-of-pocket exposure before receiving care.
PatientRightsAdvocate.org's price transparency tracking shows that compliance with federal hospital price transparency requirements has improved substantially in 2025–2026, with more than 80% of hospitals now publishing machine-readable files. Physician office pricing remains less transparent, but CMS's physician office visit cost data provides national averages that can serve as reasonable benchmarks for local estimates.
For telehealth specifically, platform websites now publish cash prices prominently—a direct response to consumer demand and state price transparency legislation. Teladoc, Amwell, CVS Health, and Amazon Clinic all list per-visit cash prices on their booking interfaces. The challenge is that these prices do not reflect insurance contracted rates, which may be higher or lower depending on the platform's payer mix and negotiated rates.
For uninsured patients, telehealth wins decisively in every city analyzed. Cash prices for telehealth range from $40–$110 across the five cities versus $110–$350 for in-person care—a 50–75% cost reduction for the same clinical encounter. Uninsured patients should prioritize telehealth platforms that publish transparent cash prices and should verify that the platform does not charge additional facility fees that are not disclosed at booking.
For commercially insured patients with low deductibles, telehealth wins modestly. The $10–$30 copay differential per visit generates $40–$120 in annual savings for patients with four annual primary care visits. However, if the patient has a concierge-style primary care relationship or requires physical examination capabilities, in-person care may justify the marginal cost premium.
For commercially insured patients with high deductibles, telehealth wins decisively. The $55–$95 out-of-pocket savings per visit compounds significantly for patients who have not yet met their annual deductible. These patients should default to telehealth for any complaint amenable to virtual evaluation until they satisfy their deductible, at which point they can reassess modality preferences based on clinical need rather than cost.
For Medicare beneficiaries, telehealth and in-person costs are effectively equivalent under standard Medicare Part B. The decision should be driven by clinical appropriateness and convenience rather than cost. However, Medicare Advantage plan enrollees may have access to $0 copay telehealth benefits that make virtual care the default choice for eligible services.
For Medicaid beneficiaries, coverage scope varies significantly by state and managed care plan. Texas Medicaid beneficiaries in Houston face more restrictive telehealth coverage than New York or Illinois Medicaid beneficiaries. Verify plan-specific benefits before assuming telehealth is covered at the same rate as in-person care.
Telehealth's cost advantage over in-person primary care is real, documented, and city-specific. New York City patients save $105–$240 per visit by choosing virtual care. Los Angeles patients save $95–$225. Chicago patients save $80–$195. Houston patients save $75–$185. Phoenix patients save $70–$160. These savings multiply with each annual visit and compound further when indirect costs are included.
The Penn Medicine finding—that telemedicine visits generate $400 less in billing and fewer follow-ups—should reshape how policymakers, employers, and patients think about virtual care investment. Telehealth is not a cheap substitute for real medicine. For the conditions that make up the majority of primary care volume, it is real medicine delivered at a structural cost advantage that benefits patients, payers, and the healthcare system as a whole.
Price-Quotes Research Lab will continue monitoring these pricing dynamics as the 2026 policy settles and telehealth platforms refine their cost structures in response to competitive pressures and regulatory changes. The data favors virtual care on cost—but only for patients who know what they are buying.